Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DIRECTA PLUS PLC Remuneration Information 2021

Jun 17, 2021

7601_def-14a_2021-06-17_05b2b610-6ebc-4b56-91b0-9b0b0c58db24.html

Remuneration Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

RNS Number : 2967C

Directa Plus PLC

17 June 2021

17 June 2021

Directa Plus plc

("Directa Plus" or the "Company")

Grant of Options

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that, on 15 June 2021, the Board approved the grant of performance-related options over a total of 150,000 ordinary shares of 0.25 pence each in the Company (the "Options") to Giorgio Bonfanti, Chief Financial Officer under the 2020 Employees' Share Scheme. 

Subject to the satisfaction of criteria related to the Company's share price performance over the period, the Options (or a portion thereof) will vest in three equal tranches on each of the first, second and third anniversaries of the date of award. 75 per cent. of the vested Options may be exercised after the third anniversary and the remaining 25 per cent. may be exercised after the fourth anniversary. The exercise price of each Option will be 118.20 pence, which is the average closing bid price of the Company's shares on the London Stock Exchange plc for the 30 days before the date of grant.

For further information please visit http://www.directa-plus.com/ or contact:

Directa Plus plc +39 02 36714458
Giulio Cesareo, CEO

Giorgio Bonfanti, CFO
Cenkos Securities plc (Nominated Adviser and Joint Broker) +44 131 220 6939
Neil McDonald

Pete Lynch
N+1 Singer (Joint Broker) +44 20 7496 3069
Rick Thompson

Phil Davies
Tavistock (Financial PR and IR) +44 20 7920 3150
Simon Hudson

Heather Armstrong

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product), textiles (based on our G+® products) and, more recently, lithium-sulphur batteries.  In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+® products.  All our products are hypoallergenic, non-toxic and sustainably produced.

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Giorgio Bonfanti
2 Reason for notification
a) Position/Status Chief Financial Officer
b) Initial notification/Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Directa Plus plc
b) LEI 213800X2DQST3K5ND898
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Grant of options under the Directa Plus plc 2020 Employees' Share Scheme
Identification code ISIN: GB00BSM98843
b) Nature of the transaction Award of Share Options
c) Price(s) and volume(s) Price Volume
118.2p 150,000
d) Aggregated information

-       Aggregated volume

-       Price
N/A Single Transaction
e) Date of the transaction 15 June 2021
f) Place of the transaction London Stock Exchange, AIM

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHDKOBQQBKDAAD